Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT02422238 Sponsor: Maastricht University Medical Center Condition: Non-Alcoholic Fatty Liver Disease
Back to Non Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease Trial, Recruiting

NCT02422238
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with a liver condition called NAFLD (a build-up of fat in the liver), confirmed by an MRI scan or a tissue sample (biopsy).
  • Your Body Mass Index (BMI) is 30 or higher (meaning you are classified as obese based on height and weight).
  • You are between 18 and 65 years old.

Who may not be able to join:

  • You are not able to understand or sign a consent form agreeing to take part in the study.
  • Your liver fat build-up is caused by another condition or reason, such as heavy drinking, certain medications, a disease called Wilson's disease, a viral infection, or extreme dieting, among other causes (confirm with trial site).
  • You drink more than 14 standard alcoholic drinks per week (if male) or more than 7 standard alcoholic drinks per week (if female).
  • You are unable or unwilling to have an MRI scan — for example, due to claustrophobia, or because you have a pacemaker or a heart device fitted.
  • You are not willing to be told about any unexpected findings discovered during your MRI scan.
  • You are unwilling to provide body fluid or tissue samples (such as blood samples) for the study.
  • You are currently pregnant or breastfeeding.
  • You are planning to have, or have already had, weight-loss (bariatric) surgery, or are expected to have it within one year of joining the trial.
  • You have been diagnosed with severe liver scarring (cirrhosis) or liver cancer.
  • You currently have, or have been diagnosed with, a cancer outside the liver within the last 5 years.
  • You are about to have, or are currently recovering from, a medical or surgical procedure that would interfere with the study — though you may be invited to join at a later date (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0031-43-3875021

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 June 2015
Est. completion
1 December 2017

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Development of NASH

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov